| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASTH | Common Stock | Award | $0 | +86.3K | +9.56% | $0.00 | 989K | Apr 2, 2024 | Direct | F3, F4 |
| holding | ASTH | Common Stock | 259K | Apr 2, 2024 | By Sim Family Irrevocable Trust 2021 | F1 | |||||
| holding | ASTH | Common Stock | 393K | Apr 2, 2024 | By Brandon Sim 2020 Irrevocable Trust | F2 |
| Id | Content |
|---|---|
| F1 | These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F2 | These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F3 | Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on October 2, 2024 (the six month anniversary of the grant date). |
| F4 | Includes 668,584 shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 14,151 shares, which vest on November 2, 2024; (ii) 81,420 shares, which vest in three equal annual installments on June 27, 2024, 2025, and 2026; (iii) 8,335 shares, which vest in three equal annual installments on June 27, 2024, 2025, and 2026; (iv) 102,613 shares, which vest in six equal semi-annual installments, beginning September 30, 2024; and (v) 462,065 shares, which vest upon achievement of certain pre-established performance goals. Also includes 86,305 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 2, 2024 (subject to continuous employment with the Issuer). |
Effective February 26, 2024, the Issuer changed its legal name from Apollo Medical Holdings, Inc. to Astrana Health, Inc.